Landmark $25.1 Million Agreement For Illegal Marketing Of Zyprexa
The State of Connecticut Attorney General’s Office Press Release announced a landmark $25.1 million agreement with drug maker Eli Lilly and Company for allegedly marketing its antipsychotic drug Zyprexa for unapproved uses, and concealing the drug’s serious side effects, for more than a decade. The Connecticut AG’s office sued Eli Lilly last year for corrupting…
Continue reading